Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
一项针对晚期实体恶性肿瘤的Veliparib(ABT-888,一种聚(ADP-核糖)聚合酶抑制剂)联合卡铂和紫杉醇的I期研究
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-019-03960-w
Appleman, Leonard J; Beumer, Jan H; Jiang, Yixing; Lin, Yan; Ding, Fei; Puhalla, Shannon; Swartz, Leigh; Owonikoko, Taofeek K; Donald Harvey, R; Stoller, Ronald; Petro, Daniel P; Tawbi, Hussein A; Argiris, Athanassios; Strychor, Sandra; Pouquet, Marie; Kiesel, Brian; Chen, Alice P; Gandara, David; Belani, Chandra P; Chu, Edward; Ramalingam, Suresh S